Cancer Incidence Projections in the United States Between 2015 and 2050
ORIGINAL RESEARCH — Volume 18 — June 10, 2021
Distribution of estimated 2015 and projected 2050 average annual cancer cases (all sites combined), by age group, United States. Numbers may not sum to total because of rounding.
|Age, y||2015 (n = 1,534,500)||2050 (n = 2,286,300)|
|<50||201,500 (13)||249,500 (11)|
|50–64||490,700 (32)||590,700 (26)|
|65–74||425,000 (28)||579,500 (25)|
|75–84||293,200 (19)||545,400 (24)|
|≥85||124,000 (8)||321,100 (14)|
Figure 2. Estimated (2015) cancer cases and projected additional cases (2050) by cancer site, United States. Numbers may not sum to total because of rounding. Abbreviation: NOS, not otherwise specified.
|Type of Cancer||2015, n||2050, n|
|Lung and bronchus||135,100||67,900|
|Colon and rectum||178,100||23,600|
|Melanoma of the skin||76,700||48,000|
|Kidney and renal pelvis||52,800||40,300|
|Corpus and uterus, NOS||54,000||38,100|
|Oral cavity and pharynx||39,700||23,900|
|Liver and intrahepatic bile duct||48,100||12,600|
|Brain and other nervous system||21,200||7,800|
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.